“A prospective study of clinical profile of type 2 lepra-reaction, clinical responses to treatment with thalidomide and seroprevalence of HIV in reactional patients” (2024) Journal of Pakistan Association of Dermatologists, 34(4), pp. 967–972. doi:10.66344/jpad.v34i4.2717.